The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.75
Bid: 16.50
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.03%)
Open: 16.75
High: 16.75
Low: 16.75
Prev. Close: 16.75
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

8 Nov 2018 07:00

RNS Number : 6885G
Inspiration Healthcare Group PLC
08 November 2018
 

8 November 2018

 

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company")

Grant of Options

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, announces that, on 7th November 2018 the Company granted enterprise management incentive options ("EMI Options") over 348,603 new ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") to certain persons discharging managerial responsibilities ("PDMRs") and employees under the Inspiration Healthcare Group plc Long Term Incentive Plan ("Option Scheme"). Following this grant, the Company has granted options over a total of 608,941 new Ordinary Shares representing approximately 2% of the Company's existing issued ordinary share capital.

The EMI Options are exercisable at nil cost and are subject to a performance condition, to be measured over a three-year period ending on 31 January 2021, of growth in earnings per Ordinary Share in issue ("EPS") of 40% or more compounded over the three-year period. If the growth in EPS is less than 40% but greater than 35% the number of EMI Options available for exercise will be capped at 75% of those granted. If the growth in EPS is less than 35% but greater than 30% the number of EMI Options available for exercise will be capped at 50% of those granted. If the growth in EPS is less than 30% the EMI Options will lapse.

If they vest and subject to the rules of the Option Scheme, the EMI Options are exercisable for a period of two years following publication of the audited accounts of the Company for the financial year ending on 31 January 2021.

The Company announces the following PDMR dealings in accordance with article 19(3) of the Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Neil Campbell

2 

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

 

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

Nil cost

65,385

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A - single transaction

 

 

 

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Briant

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial

3 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

 Identification code

 

Ordinary Shares of 10p each

 

 

ISIN: GB00BXDZL105

 

b)

Nature of the transaction

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil cost

86,014

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A - single transaction

 

 

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Toby Foster

2

Reason for the notification

a)

Position/status

Group Sales Director

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

 

Description of the financial instrument, type of instrument

 

 Identification code

Ordinary Shares of 10p each

 

 

 

ISIN: GB00BXDZL105 

b)

Nature of the transaction

Grant of Options

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

Nil cost

57,692

 

d)

 

Aggregated information

 

 - Aggregated volume

 

- Price

 

 

 

 

N/A - single transaction

 

 

 

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Simon Travers

2

Reason for the notification

a)

Position/status

Head of Regulatory Affairs and Quality Assurance

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name 

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

 

ISIN: GB00BXDZL105 

b)

Nature of the transaction

Grant of Options

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

Nil cost

23,252

 

d)

 

Aggregated information-

 

Aggregated volume

 

 - Price 

 

 

 

N/A - single transaction

 

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 

Jon Ballard

2

Reason for the notification

a)

Position/status 

Group Financial Controller

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

 

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

Nil cost

23,252

d)

 

Aggregated information

 

 - Aggregated volume

 

 - Price

 

 

 

 

 N/A - single transaction

 

 

 

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

John Nash

2

Reason for the notification

a)

Position/status

Head of Marketing

b)

Initial notification /Amendment

Initial

3 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 10p each

 

 

 

ISIN: GB00BXDZL105

 

b)

Nature of the transaction

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil cost

23,252

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

N/A - single transaction

 

 

e)

 

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Wei Yu

2 

Reason for the notification

a)

Position/status

 Head of R&D

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 10p each

 

 

 

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil cost

23,252

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

N/A - single transaction

 

 

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

 

 

Enquiries:

Inspiration Healthcare Group plc

 

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer

 

 

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

 

Mark Connelly (NOMAD) 

 

 

 

Tel: 0207 397 8900

 

Cadogan PR

Alex Walters

 

 

Tel: 07771 713608

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQDLFBVFFXFBD
Date   Source Headline
28th Nov 20229:00 amRNSPrice Monitoring Extension
28th Nov 20227:00 amRNSUpdate on Trading
9th Nov 20227:00 amRNSUkraine Order
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
4th Oct 20222:05 pmRNSSecond Price Monitoring Extn
4th Oct 20222:00 pmRNSPrice Monitoring Extension
4th Oct 202211:05 amRNSSecond Price Monitoring Extn
4th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSInterim Results
21st Sep 20227:00 amRNSSignificant Japanese Order
1st Sep 20227:00 amRNSResults date and Investor events
15th Aug 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSCapital Markets Day
30th Jun 202212:58 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement
10th Jun 20221:00 pmRNSExercise of options and Total Voting Rights
7th Jun 20227:00 amRNS£1.3 million Iraq Order
6th Jun 20227:00 amRNSAnnual Report 2022 and Notice of AGM
24th May 20227:00 amRNSTR1 Notification
20th May 20223:09 pmRNSTR1 Notification
19th May 20227:00 amRNSMello Investor Conference
4th May 20227:00 amRNSFinal Results
25th Apr 20227:05 amRNSInvestor Presentation
8th Apr 20222:21 pmRNSGrant of Options
1st Apr 20227:00 amRNSLaunch of test to avoid hearing loss in neonates
17th Feb 20227:00 amRNSPost Period Trading Update and Notice of Results
14th Feb 20227:00 amRNS$1.37 million Egyptian Order
1st Feb 20229:00 amRNSCenkos Virtual Growth and Innovation Forum
9th Dec 20214:15 pmRNSTR1 Notification
9th Dec 20214:15 pmRNSTR1 Notification
2nd Dec 20217:00 amRNSCapital Markets Day
29th Oct 20213:07 pmRNSDirector/PDMR Shareholding
25th Oct 202110:15 amRNSReplacement: Director/PDMR Shareholding
22nd Oct 20214:35 pmRNSDirector/PDMR Shareholding
20th Oct 20215:02 pmRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSInterim Results
4th Oct 20217:00 amRNSTR1 Notification
24th Sep 20217:00 amRNSNotice of Results, Mello and AIM Awards
11th Aug 20217:00 amRNSTrading Update
27th Jul 202110:13 amRNSDirector/PDMR Shareholding
12th Jul 20217:00 amRNSTR1 Notification
25th Jun 202112:43 pmRNSResult of AGM
25th Jun 20217:00 amRNSAGM Statement
23rd Jun 20211:15 pmRNSAGM Notice
22nd Jun 20217:00 amRNSProject WAVE recruits first patient
16th Jun 20219:18 amRNSDirector/PDMR Shareholding
16th Jun 20217:00 amRNSCapital Markets Day
28th May 20217:00 amRNSAnnual Report 2021 and Notice of AGM
20th May 20212:15 pmRNSMello Healthcare Presentation 25th May 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.